• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.03% Nasdaq Up 1.29%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    5.24 May 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.24
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:8.67
    Beta:2.69
    Next Earnings Date: 6-May-15PGNX Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:3.10 - 7.84
    Volume:0
    Avg Vol (3m):895,470
    Market Cap:364.91M
    P/E (ttm):87.33
    EPS (ttm):0.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNX 0.00%364.91M
    DNDNN/A
    NKTR1.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.22
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.16
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback